Anebulo Pharmaceuticals, Inc.

NASDAQ:ANEB

1.5955 (USD) • At close January 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 1.4043.0945.1476.6458.52111.24714.16516.35519.21414.54816.54818.00919.20819.9863.3072.48-3.0253.025
Short Term Investments 00000000000000006.050
Cash and Short Term Investments 1.4043.0945.1476.6458.52111.24714.16516.35519.21414.54816.54818.00919.20819.9863.3072.483.0253.025
Net Receivables 000000000000000.023000.004
Inventory 000000000000000000
Other Current Assets 0.5580.4140.4470.3430.5270.4230.2680.5330.6021.0310.7010.9551.2931.6680.5690.02900
Total Current Assets 1.9633.5085.3716.8169.04811.6714.43316.88819.81514.54817.24818.96420.519.9863.8992.5093.0253.028
Non-Current Assets:
Property, Plant & Equipment, Net 000000000000000000
Goodwill 000000000000000000
Intangible Assets 000000000000000000
Goodwill and Intangible Assets 000000000000000000
Long Term Investments 000000000000000000
Tax Assets 000000000000000000
Other Non-Current Assets 0.5050.5650.6250.68500.42300000001.6680.3930.102-3.0250
Total Non-Current Assets 0.5050.5650.6250.68500.4230001.0310001.6680.3930.102-3.0250
Total Assets 2.4684.0735.9967.5019.04811.6714.43316.88819.81515.57917.24818.96420.521.6534.2912.61103.028
Liabilities & Equity:
Current Liabilities:
Account Payables 0.2520.1560.3850.3190.5660.5350.5710.3470.5230.3810.0830.0430.4940.110.0820.08400
Short Term Debt 0000000000000000.20900.201
Tax Payables 000000000000000000
Deferred Revenue 000000000000000000
Other Current Liabilities 0.3170.1040.62500.1510.5340.921.0260.1750.1320.0030.0070.1140.1320.2110.0600.023
Total Current Liabilities 0.5690.2611.011.0140.7171.0691.4911.3720.6980.5130.0860.050.6080.2420.2930.35400.224
Non-Current Liabilities:
Long Term Debt 000000000000000000
Deferred Revenue Non-Current 000000000000000000
Deferred Tax Liabilities Non-Current 000000000000000000
Other Non-Current Liabilities 0000000000000013.4342.97600
Total Non-Current Liabilities 000.6250.6950.1510.5340.5711.02600.3810.0830.0430.4940.1113.4342.97600
Total Liabilities 0.5690.2611.011.0140.7171.0691.4911.3720.6980.5130.0860.050.6080.24213.7273.3300.224
Equity:
Preferred Stock 000000000000021.6532,975.7522.9762.9762.976
Common Stock 0.0260.0260.0260.0260.0260.0260.0260.0260.0260.0230.0230.0230.0230.0230.0130.01300.012
Retained Earnings -67.604-65.404-64.054-62.4-59.683-57.202-54.706-51.908-48.082-45.47-43.147-41.27-40.197-38.644-9.532-0.7680-0.183
Accumulated Other Comprehensive Income/Loss 000000-0-000-000-0-2,975.752-0-0.1710
Other Total Stockholders Equity 69.47769.1969.01368.86267.98967.77867.62267.39967.17360.51360.28660.16160.06760.0332,978.811-2.92900
Total Shareholders Equity 1.8993.8134.9856.4878.33110.60112.94215.51619.11715.06717.16318.91419.89321.412-9.436-0.7192.8052.805
Total Equity 1.8993.8134.9856.4878.33110.60112.94215.51619.11715.06717.16318.91419.89321.412-9.436-0.7192.8052.805
Total Liabilities & Shareholders Equity 2.4684.0735.9967.5019.04811.6714.43316.88819.81515.57917.24818.96420.521.6534.2912.6112.8053.028